[Treatment of schizophrenic patients with depot-neuroleptics.].
During almost four decades neuroleptic drugs have been the main weapon in doctor's armamentarium against schizophrenia and some other major psychiatric disorders. In Iceland seven different depot-neuroleptics from three subgroups are used. The main indication for depot-neuroleptics is to insure that the patient gets the prescribed amount of medication and to prevent a relapse from noncompliance. Depot-neuroleptics have the same side effects as neuroleptics in general. The main focus in this paper is on the following side effects: Extrapyramidal symptoms, tardive dyskinesia, psychic symptoms and neuroleptic malignant-syndrome.